Dia 1

443 / 1196

• Multicenter study
• Prospective
• Inoperable T1/T2 NSCLC
• N=60
• Period: 2003-2005
• SBRT
• Dose: 45 Gy at 15 Gy/fx
• Grade 3 toxicity: 21%
• Local control 96%
• OS: 65%
Baumann et al. Radiotherapy and Oncology 88 (2008) 359–367